Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Henry Schein (HSIC)
NASDAQ:HSIC
Holding HSIC?
Track your performance easily
HSIC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$63.67 - $82.63
Previous CloseN/A
Volume226.89K
Average Volume (3M)1.19M
Market Cap
$9.35B
Enterprise Value$13.64B
Total Cash (Recent Filing)$62.38M
Total Debt (Recent Filing)$715.46M
Price to Earnings (P/E)30.7
Beta0.53
Next Earnings
Feb 12, 2025EPS Estimate
1.23Last Dividend Ex-Date
Feb 08, 2019Dividend YieldN/A
Share Statistics
EPS (TTM)2.44
Shares Outstanding124,681,300
10 Day Avg. Volume1,048,889
30 Day Avg. Volume1,185,620
Standard Deviation0.08
R-Squared0.34
Alpha-0.00645
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.75
Price to Cash Flow (P/CF)15.50
P/FCF Ratio16.30
Enterprise Value/Market Cap1.46
Enterprise Value/Revenue1.09
Enterprise Value/Gross Profit3.53
Enterprise Value/Ebitda19.05
Forecast
1Y Price Target
$79.55Price Target Upside-0.56% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Henry Schein News
Bulls Say, Bears Say
Bulls Say
Market PositionHSIC is the largest distributor of healthcare products and services to office-based practitioners in North America and Europe.
Operational ImprovementsManagement implemented several efforts which have generated $50MM+ of annual run-rate-savings, and are on track to generate annual run-rate savings of $75MM-$100MM by the end of 2025.
Strategic InvestmentKKR, a well-known PE firm, taking a material stake in HSIC is a significant vote of confidence regarding HSIC’s inherent value.
Bears Say
Financial PerformanceHenry Schein has reported nine consecutive quarters of organic sales declines, and there are doubts about whether this negative trend will improve in 2025.
Market ConditionsThe Mizuho U.S. dental survey suggests that the challenging industry trends seen in 2024 are unlikely to improve in 2025, which is considered negative for dental distributors.
Operational ChallengesHenry Schein has faced challenges in growing organic sales due to economically soft end-markets and an unexpected cyber-attack.
---
Ownership Overview
1.39% Insiders
31.41% Mutual Funds
0.42% Other Institutional Investors
40.70% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HSIC FAQ
What was Henry Schein’s price range in the past 12 months?
Henry Schein lowest stock price was $63.67 and its highest was $82.63 in the past 12 months.
What is Henry Schein’s market cap?
Henry Schein’s market cap is $9.35B.
When is Henry Schein’s upcoming earnings report date?
Henry Schein’s upcoming earnings report date is Feb 12, 2025 which is in 10 days.
How were Henry Schein’s earnings last quarter?
Henry Schein released its earnings results on Nov 05, 2024. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05.
Is Henry Schein overvalued?
According to Wall Street analysts Henry Schein’s price is currently Overvalued.
Does Henry Schein pay dividends?
Henry Schein pays a Notavailable dividend of $17.219 which represents an annual dividend yield of N/A. See more information on Henry Schein dividends here
What is Henry Schein’s EPS estimate?
Henry Schein’s EPS estimate is 1.23.
How many shares outstanding does Henry Schein have?
Henry Schein has 124,681,300 shares outstanding.
What happened to Henry Schein’s price movement after its last earnings report?
Henry Schein reported an EPS of $1.22 in its last earnings report, beating expectations of $1.17. Following the earnings report the stock price went down -4.618%.
Which hedge fund is a major shareholder of Henry Schein?
Currently, no hedge funds are holding shares in HSIC
---
Henry Schein Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$79.55 (-0.56% Downside)
$79.55 (-0.56% Downside)
Blogger Sentiment
Bullish
HSIC Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 4.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.6%
Last 30 Days ▲ 6.2%
Last 30 Days ▲ 6.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
2.33%
12-Months-Change
Fundamentals
Return on Equity
8.96%
Trailing 12-Months
Asset Growth
8.10%
Trailing 12-Months
Company Description
Henry Schein
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
---
HSIC Company Deck
---
HSIC Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a balanced view of the company's performance. While there were significant achievements like the increase in EPS guidance and strong performance in high-growth areas, challenges such as declines in medical sales and lingering effects of the cyber incident were noted.Read More>---
HSIC Revenue Breakdown
93.47% Health care distribution
6.53% Technology and value-added services
---
HSIC Stock 12 Month Forecast
Average Price Target
$79.55
▼(-0.56% Downside)
Technical Analysis
Baxter International
―
Cardinal Health
―
McKesson
―
Omega Healthcare
―
Patterson Companies
―
Best Analysts Covering HSIC
1 Year
1 Year Success Rate
11/18 ratings generated profit
1 Year Average Return
+3.38%
assigned a buy rating 3 months ago
Copying Jason Bednar's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +3.38% per trade.
---